Interventioneller Mitralklappenersatz: Indikationen, Möglichkeiten und Technik sowie wichtige Aspekte für die perioperative Betreuung

Michael Grund; Ilinca Damian; Jörg Kellermair; Andreas Florian Zierer

doi:10.1007/s00063-022-00907-7

Interventioneller Mitralklappenersatz: Indikationen, Möglichkeiten und Technik sowie wichtige Aspekte für die perioperative Betreuung

Translated title of the contribution: Transcatheter mitral valve replacement: Indications, options, and techniques as well as important aspects for perioperative care

Department of Cardiovascular and Thoracic Surgery

Research output: Contribution to journal › Article › peer-review

Abstract

Transcatheter therapy of the mitral valve is more challenging compared to the aortic valve. Interventional therapy with the Mitra-Clip system, mimicking the surgical edge-to-edge repair, was first introduced in 2003 and received the CE mark in 2008. The first implantation of the Tendyne system, which is currently the only commercially available system for mitral valve replacement, was performed in 2014, and routine clinical use was approved in 2020. Several new valve platforms are in clinical development and will expand the treatment portfolio. This article will discuss the clinical indications, technical challenges and specific requirements for perioperative management.

Translated title of the contribution	Transcatheter mitral valve replacement: Indications, options, and techniques as well as important aspects for perioperative care
Original language	German (Austria)
Pages (from-to)	187-190
Number of pages	4
Journal	Medizinische Klinik - Intensivmedizin und Notfallmedizin
Volume	117
Issue number	3
DOIs	https://doi.org/10.1007/s00063-022-00907-7
Publication status	Published - Apr 2022

Fields of science

302081 Thoracic surgery
302026 Heart surgery
302018 Vascular surgery

Access to Document

10.1007/s00063-022-00907-7

Cite this

@article{f69811a48a8e43fe9f521078c30c0258,

title = "Interventioneller Mitralklappenersatz: Indikationen, M{\"o}glichkeiten und Technik sowie wichtige Aspekte f{\"u}r die perioperative Betreuung",

abstract = "Transcatheter therapy of the mitral valve is more challenging compared to the aortic valve. Interventional therapy with the Mitra-Clip system, mimicking the surgical edge-to-edge repair, was first introduced in 2003 and received the CE mark in 2008. The first implantation of the Tendyne system, which is currently the only commercially available system for mitral valve replacement, was performed in 2014, and routine clinical use was approved in 2020. Several new valve platforms are in clinical development and will expand the treatment portfolio. This article will discuss the clinical indications, technical challenges and specific requirements for perioperative management.",

author = "Michael Grund and Ilinca Damian and J{\"o}rg Kellermair and Zierer, \{Andreas Florian\}",

year = "2022",

month = apr,

doi = "10.1007/s00063-022-00907-7",

language = "Deutsch ({\"O}sterreich)",

volume = "117",

pages = "187--190",

journal = "Medizinische Klinik - Intensivmedizin und Notfallmedizin",

number = "3",

}

TY - JOUR

T1 - Interventioneller Mitralklappenersatz

T2 - Indikationen, Möglichkeiten und Technik sowie wichtige Aspekte für die perioperative Betreuung

AU - Grund, Michael

AU - Damian, Ilinca

AU - Kellermair, Jörg

AU - Zierer, Andreas Florian

PY - 2022/4

Y1 - 2022/4

N2 - Transcatheter therapy of the mitral valve is more challenging compared to the aortic valve. Interventional therapy with the Mitra-Clip system, mimicking the surgical edge-to-edge repair, was first introduced in 2003 and received the CE mark in 2008. The first implantation of the Tendyne system, which is currently the only commercially available system for mitral valve replacement, was performed in 2014, and routine clinical use was approved in 2020. Several new valve platforms are in clinical development and will expand the treatment portfolio. This article will discuss the clinical indications, technical challenges and specific requirements for perioperative management.

AB - Transcatheter therapy of the mitral valve is more challenging compared to the aortic valve. Interventional therapy with the Mitra-Clip system, mimicking the surgical edge-to-edge repair, was first introduced in 2003 and received the CE mark in 2008. The first implantation of the Tendyne system, which is currently the only commercially available system for mitral valve replacement, was performed in 2014, and routine clinical use was approved in 2020. Several new valve platforms are in clinical development and will expand the treatment portfolio. This article will discuss the clinical indications, technical challenges and specific requirements for perioperative management.

UR - https://www.scopus.com/pages/publications/85126488105

U2 - 10.1007/s00063-022-00907-7

DO - 10.1007/s00063-022-00907-7

M3 - Artikel

C2 - 35304641

VL - 117

SP - 187

EP - 190

JO - Medizinische Klinik - Intensivmedizin und Notfallmedizin

JF - Medizinische Klinik - Intensivmedizin und Notfallmedizin

IS - 3

ER -

Interventioneller Mitralklappenersatz: Indikationen, Möglichkeiten und Technik sowie wichtige Aspekte für die perioperative Betreuung

Abstract

Fields of science

Access to Document

Other files and links

Cite this